A comparison of the Cohen-Mansfield agitation inventory with the cerad behavioral rating scale for dementia in community-dwelling persons with Alzheimers disease

In a group of 242 community-dwelling patients with Alzheimers disease (AD), a longitudinal comparison was made of two caregiver-administered instruments for assessment of behavioral disturbance; the Cohen-Mansfield Agitation Inventory (CMAI) and the CERAD Behavioral Rating Scale for Dementia (BRSD)....

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychiatric research 1998-11, Vol.32 (6), p.347-351
Main Authors: Weiner, Myron F, Koss, Elisabeth, Patterson, Marian, Jin, Shelia, Teri, Linda, Thomas, Ron, Thal, Leon J, Whitehouse, Peter
Format: Article
Language:English
Subjects:
Activities of Daily Living - psychology
Alzheimer Disease - diagnosis
Biological and medical sciences
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Disease Progression
Female
Follow-Up Studies
Humans
Longitudinal Studies
Male
Medical sciences
Neurology
Outpatients
Psychiatric Status Rating Scales - standards
Psychology. Psychoanalysis. Psychiatry
Psychometrics
Psychometrics. Diagnostic aid systems
Psychomotor Agitation - psychology
Psychopathology. Psychiatry
Reproducibility of Results
Techniques and methods
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a group of 242 community-dwelling patients with Alzheimers disease (AD), a longitudinal comparison was made of two caregiver-administered instruments for assessment of behavioral disturbance; the Cohen-Mansfield Agitation Inventory (CMAI) and the CERAD Behavioral Rating Scale for Dementia (BRSD). We examined records of the 206 patients with baseline and 12-month follow-up data for the CMAI and the BRSD who also had tests of cognitive (Mini-mental State; MMSE) and global function (Clinical Dementia Rating; CDR and Functional Assessment Staging; FAST). Among 114 AD subjects, the correlation between total CMAI at baseline and 1 month readministration was 0.83 ( p
ISSN:0022-3956
1879-1379
DOI:10.1016/S0022-3956(98)00027-2